These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2250979)

  • 1. The use of nimodipine (Nimotop-Bayer) in patients with chronic ischemic cerebral vasculopathies. Twenty-eight case reports.
    Politi GC; Romanini BM; Belloli PA; Rossi A; Bellaviti N; Pucci C; Ferro C
    Panminerva Med; 1990; 32(2):85-7. PubMed ID: 2250979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nimodipine in ischemic cerebropathy].
    Di Lascio G; Salvini S
    Clin Ter; 1993 Feb; 142(2):123-6. PubMed ID: 8472525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
    Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of nimodipine in comatose patients with different types of cerebrovascular pathology].
    Alia G; Mattaliano A
    Clin Ter; 1993 Oct; 143(4):295-301. PubMed ID: 8258263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke.
    Nag D; Garg RK; Varma M
    Indian J Physiol Pharmacol; 1998 Oct; 42(4):555-8. PubMed ID: 10874361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
    Di Mascio R; Marchioli R; Tognoni G
    Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
    Dalal PM; Dalal KP
    J Assoc Physicians India; 1995 Jun; 43(6):394-7. PubMed ID: 8906943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of nimodipine on mental deterioration in subjects with chronic cerebrovascular pathology].
    Canadè V; Catapano F; Muraca L; Cosentino A
    Minerva Med; 1991 Mar; 82(3):111-4. PubMed ID: 2006028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does nimodipine improve the outcome of perioperative complications of aneurysm rupture? Results of systematic treatment].
    Ades PE; Fabre M; Aesch B; Rieant JF; Buchet S; Lamotte C; Jan M
    Agressologie; 1989 Jun; 30(7):431-6. PubMed ID: 2817239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamic profile in patients presenting with cerebral arterial spasm after meningeal hemorrhage in the presence of preventive administration of i.v. nimodipine].
    Adnet P; Fesard P; Riegel B; Runge I; Lejeune JP; Krivosic-Horber R
    Ann Fr Anesth Reanim; 1989; 8 Suppl():R84. PubMed ID: 2604269
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of the preparation Nimotop in neurosurgical patients].
    Amcheslavskiĭ VG; Demchuk ML; Madorskiĭ SV; Toma GI; Margishvili GM; Fokin MS; Savin IA
    Zh Vopr Neirokhir Im N N Burdenko; 1997; (3):41-3. PubMed ID: 9424955
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experiences with nimodipine in cerebral ischemia.
    Kakarieka A; Schakel EH; Fritze J
    J Neural Transm Suppl; 1994; 43():13-21. PubMed ID: 7884395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nimotop: clinical spectrum].
    Shirokov EA; Denishchuk IS; Polkhovskiĭ AA
    Klin Med (Mosk); 1998; 76(5):37-40. PubMed ID: 9644935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatosensory evoked potentials quantify clinical improvement of cerebral vasospasm after intravenous administration of nimodipine.
    Lipschitz R; Davidson K; Strugo V
    S Afr Med J; 1988 Oct; 74(8):403-5. PubMed ID: 3187819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reversible segmental cerebral vasoconstriction: the value of duplex transcranial Doppler in its diagnosis and follow up].
    Rubiera del Fueyo M; Molina Cateriano CA; Arenillas Lara JF; Pelayo Vergara R; Santamarina E; Romero Vidal FJ; Alvarez Sabín J
    Rev Neurol; 2004 Mar 16-31; 38(6):530-3. PubMed ID: 15054716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic cerebrovascular insufficiency: comparison of nimodipine and dihydroergotoxine].
    Cosmi F; Caresia L; Panebianco G
    Clin Ter; 1986 Feb; 116(3):213-20. PubMed ID: 3698528
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical experiences with nimodipine treatment in patients after SAH and aneurysm surgery.
    Wroński J; Abraszko R; Berny W; Mierzwa J
    Zentralbl Neurochir; 1990; 51(1):21-3. PubMed ID: 2275300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous nimodipine in the treatment of cerebral vasospasm following subarachnoid hemorrhage caused by aneurysm rupture: a comparative multicenter study].
    Desbordes JM; Ades PE; Guggiari M
    Agressologie; 1989 Jun; 30(7):438-40. PubMed ID: 2683824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.